Ocuphire Pharma, Inc. (OCUP) Reports Q2 Loss, Lags Revenue Estimates

Ocuphire Pharma, Inc. (OCUP) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of$ 0.29. This compares to loss of $0.24 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -3.45%. A quarter ago, it was expected that this company would post a loss of$ 0.18 per share when it actually produced a loss of $0.29, delivering a surprise of -61.11%. Over the last four quarters, the company has ...